High occurrence of CYP3A5 variants among breast cancer and organ transplant patients
Abstract CYP3A5 is one of the important drug metabolising enzyme and its polymorphism shows marked differences in protein expression and catalytic activities between different geographical ethnic groups. Both tamoxifen and tacrolimus are substrates of CYP3A5 and thus the polymorphism may cause phar...
Saved in:
Main Authors: | Ismail, S, Mohammad, NI, Hamzah, S, Mohamad , R, Harun, R, Suhaimi, S, Jaszle, S, Sood, S, Henry, F, Shabery, A, Rajoo, T, Bahri, R, Muniandy, S, Ismail, G, Wong, H. S., Abdullah Ngow, Harris, U Kyaw, T. H., Jalaludin, K, Din, J, Hatta, F. H., Teh, L. K., Salleh, M. Z. |
---|---|
Format: | Conference or Workshop Item |
Language: | English |
Published: |
2010
|
Subjects: | |
Online Access: | http://irep.iium.edu.my/5235/1/Abstract_for_NCCR_2010_cyp3a5a.pdf http://irep.iium.edu.my/5235/ http://www.nccr.gov.my/index.cfm?menuid=28 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Genetic Polymorphism of CYP2D6 and MDR1 in breast cancer patients treated with tamoxifen
by: Mohamad, NI, et al.
Published: (2010) -
Role of pharmacodiagnostic of CYP2C9 variants in the optimization of warfarin therapy in Malaysia: a 6-month follow-up study
by: Ngow, Harris Abdullah, et al.
Published: (2008) -
The Risk of Recurrence in Breast Cancer Patients Treated with Tamoxifen: Polymorphisms of CYP2D6 and ABCB1
by: Teh, L. K., et al.
Published: (2011) -
Heterogeneity of the CYP2D6 gene among Malays in Malaysia
by: Teh, L.K., et al.
Published: (2001) -
Pharmacogenotyping of CYP3A5 in predicting dose-adjusted trough levels of tacrolimus among Malaysian kidney-transplant patients
by: Hamzah, Sharina, et al.
Published: (2014)